Randomised, controlled, double-blind trial of Chinese Herbal Medicine as adjuvant treatment in patients with Crohn's disease

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

ISRCTN

Registry ID

ISRCTN69696725

Enrollment

Registered

2002-05-29

Start date

2000-04-01

Completion date

Unknown

Last updated

2015-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Crohn's disease Digestive System Crohn's disease [regional enteritis]

Interventions

1. Chinese Herbal Medicine Preparation (capsuled pulverised Chinese Medicinal Recipe

11 drugs) to be taken for 12 weeks

9 g daily 2. Placebo (identical in taste and flavour)

12 weeks, 9 g daily

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. 60 participants 2. Disease duration greater than 1 year 3. Crohn's Disease Activity Index (CDAI) 150 - 450 4. Aged 18 - 60 years

Exclusion criteria

Exclusion criteria: Not provided at time of registration.

Design outcomes

Primary

Measure	Time frame
Not provided at time of registration.	—

Secondary

Measure	Time frame
Not provided at time of registration.	—

Countries

Germany

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026